pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 19·1 min read
save

Q&A: Novo research chief Petersen says streamlined R&D speeds discovery

Just as Maziar Mike Doustdar took the helm at Novo Nordisk in the summer of 2025, the company said it would reorganize its R&D activities, merging the teams that focused on early ...

May 19, 2026·read at Endpoints ↗

Jacob Sten Petersen, Novo Nordisk head of global research May 19, 2026 11:22 AM EDT PeopleR&D Q&A: No­vo Nordisk re­search chief dis­cuss­es stream­lined R&D, as­set in­te­gra­tion and role of AI Elizabeth Cairns Senior biopharma journalist Just as Maziar Mike Doust­dar took the helm at No­vo Nordisk in the sum­mer of 2025, the com­pa­ny said it would re­or­ga­nize … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
92 words · retrieved May 19
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
NOVO3Novo Nordisk Inc2

related stories

  • May 18STAT+: Supreme Court rejects challenge to Medicare drug price negotiationSTAT
  • May 13Lilly data point to ‘maintenance’ strategies for GLP-1 weight lossBioPharma Dive
  • May 13STAT+: Pharmalittle: We’re reading about FDA’s Makary resigning, a Lilly weight loss drug trial, and moreSTAT
  • May 12STAT+: Pharmalittle: We’re reading about pharma lobbying, Bristol’s deal with a Chinese partner, and moreSTAT
  • May 12A year after Vertex’s big launch, pain drug research faces a pivotal momentBioPharma Dive